DiscoverProgress, Potential, and Possibilities Podcast / ShowDave Rosa - CEO, NeuroOne - The Next Frontier of Neurology - Thin Film Electrode Technologies for Stimulation, Recording, and Monitoring of Brain Activity
Dave Rosa -  CEO, NeuroOne - The Next Frontier of Neurology - Thin Film Electrode Technologies for Stimulation, Recording, and Monitoring of Brain Activity

Dave Rosa - CEO, NeuroOne - The Next Frontier of Neurology - Thin Film Electrode Technologies for Stimulation, Recording, and Monitoring of Brain Activity

Update: 2025-11-15
Share

Description

Send us a text

Dave Rosa is President & Chief Executive Officer of NeuroOne ( https://nmtc1.com/ ), a developmental-stage medical technology company developing high-definition, minimally invasive thin film electrodes for the diagnosis and treatment of various neurological conditions ( https://nmtc1.com/technology ). The company’s initial focus is on epilepsy and the fast‑growing neurostimulation device market.

Mr. Rosa is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products. 

In addition to CEO roles with early-stage medical device companies, Mr. Rosa’s background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets. 

Mr. Rosa holds an MBA from Duquesne University and a BS in Commerce and Engineering from Drexel University.

IMPORTANT EPISODE LINKS - 

Electrochemical Testing of a New Polyimide Thin Film Electrode for Stimulation, Recording, and Monitoring of Brain Activity -

https://pmc.ncbi.nlm.nih.gov/articles/PMC9611492/

First Food and Drug Administration Cleared Thin-Film Electrode for Intracranial Stimulation, Recording, and Monitoring of Brain Activity—Part 1: Biocompatibility Testing -

https://pmc.ncbi.nlm.nih.gov/articles/PMC9100917/

#NeuroOne #DaveRosa #MinimallyInvasive #ThinFilmElectrodes #Theranostics #Stereoelectroencephalography #NeurologicalConditions #Epilepsy #MovementDisorders #ChronicPain #PsychiatricDisorders #Glioblastoma #CognitiveDisorders #Neurostimulation #NerveAblation #BloodBrainBarrier #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research

Support the show

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Dave Rosa -  CEO, NeuroOne - The Next Frontier of Neurology - Thin Film Electrode Technologies for Stimulation, Recording, and Monitoring of Brain Activity

Dave Rosa - CEO, NeuroOne - The Next Frontier of Neurology - Thin Film Electrode Technologies for Stimulation, Recording, and Monitoring of Brain Activity

Ira Pastor / Dave Rosa